Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
29 Februar 2024 - 2:00PM
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage,
oncology-focused biopharmaceutical company developing proprietary
antibody-based therapeutics to treat multiple human diseases, today
announced that the Company will participate in the Leerink Partners
Global Biopharma Conference in Miami Beach, Florida on Wednesday,
March 13, 2024.
Fireside Chat
detailsDate: Wednesday, March 13,
2024Time: 10:40 AM ET Webcast
Link: https://wsw.com/webcast/
Virtual/Replay availability: The corporate
presentation will be archived for 90 days on
Compass’ Events page.
About Compass TherapeuticsCompass Therapeutics,
Inc. is a clinical-stage, oncology-focused biopharmaceutical
company developing proprietary antibody-based therapeutics to treat
multiple human diseases. Compass’s scientific focus is on the
relationship between angiogenesis, the immune system, and tumor
growth. Compass’s pipeline of novel product candidates is designed
to target multiple critical biological pathways required for an
effective anti-tumor response. These include modulation of the
microvasculature via angiogenesis-targeted agents, induction of a
potent immune response via activators on effector cells in the
tumor microenvironment, and alleviation of immunosuppressive
mechanisms used by tumors to evade immune surveillance. Compass
plans to advance its product candidates through clinical
development as both standalone therapies and in combination with
proprietary pipeline antibodies based on supportive clinical and
nonclinical data. Compass was founded in 2014 and is headquartered
in Boston, Massachusetts. For more information, visit the Compass
Therapeutics, Inc. website
at www.compasstherapeutics.com.
Investor
Contactir@compasstherapeutics.com
Media ContactAnna Gifford, Senior Manager of
Communicationsmedia@compasstherapeutics.com617-500-8099
Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024